Mark McClung
Keine laufenden Positionen mehr
Vermögen: 62 828 $ am 31.05.2024
Karriereverlauf von Mark McClung
Ehemalige bekannte Positionen von Mark McClung
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Geschäftsführer | 01.11.2021 | 02.01.2024 |
| Corporate Officer/Principal | 17.04.2020 | 01.11.2021 | |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2015 | 01.01.2019 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | - | - |
Ausbildung von Mark McClung
| University of Guelph | Undergraduate Degree |
| York University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Kanada | 3 |
Operativ
| Undergraduate Degree | 3 |
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
- Börse
- Insiders
- Mark McClung
- Erfahrung
